Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

SLE Prevalence Jumped 60% in a Decade in US

Publish date:: May 27, 2019

Key clinical point: There are confounders, but there has also likely been an actual increase in SLE cases in the United States.

Major finding: The prevalence of systemic lupus erythematosus in the United States increased 6% a year during 2001-2011, for a cumulative increase of 59.4%.

Study details: Review of nationwide CDC databases.

Disclosures: The work was funded by the National Institutes of Health, among others. The senior investigator didn’t have any relevant disclosures.

Citation:

Nguyen KP et al. Lupus Sci Med. 2019;6[suppl 1]: Abstract 166. doi: 10.1136/lupus-2019-lsm.166.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Must Reads in Lupus & Connective Tissue Diseases

High-need, high-cost lupus patients described for first time,

Slow taper off antimalarial is best to avoid lupus flare during remission,

Sjögren’s symptom clusters may identify treatment options,

Transcutaneous VNS on the ear shows positive effects in lupus pilot trial,

ASSET extension supports abatacept as treatment for diffuse cutaneous systemic sclerosis,